The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100. (Q41188809)
Jump to navigation
Jump to search
scientific article published on July 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100. |
scientific article published on July 1996 |
Statements
1 reference
The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100. (English)
1 reference
Zarour H
1 reference
De Smet C
1 reference
Lehmann F
1 reference
Marchand M
1 reference
Lethé B
1 reference
Romero P
1 reference
Boon T
1 reference
Renauld JC
1 reference
1 July 1996
1 reference
1 reference
Identifiers
1 reference